Social Media Influencers Fueling Parallel Trade for Unapproved Weight-Loss Medication

An underground economy for unapproved slimming drugs is being driven by TikTok fitness influencers and vendors on communication apps, based on recent findings.

Experimental Drug Acquiring Popularity Via Social Media

The experimental drug, which remains in clinical trials, is being promoted by social media influencers for its supposed weight-reducing effects. Followers are urged to message these accounts privately for supplier links, while also obtaining promotional offers.

Active Trade on Social Networks

Separately, a robust trade exists on messaging services, where communities with thousands of members share comparison photos, administration instructions and assertions of rapid British shipping. Vendors market the substance there before directing customers to other platforms for purchases.

Learning About Retatrutide

Retatrutide is an investigational injection created by American pharmaceutical company Eli Lilly. The drug targets three intestinal hormones – GLP-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Preliminary studies suggest it could assist individuals lose up to a quarter of their body weight. Nicknamed the “triple G”, the drug is being promoted online as the next Ozempic.

Medical Professionals Voice Worries

Nevertheless, physicians and pharmacists have warned that the sale of what is still an unlicensed drug in the UK is a cause for concern and could result in users administering products of uncertain source.

Several experts said the demand for retatrutide could be connected to the rising price of approved slimming treatments such as Mounjaro.

Legal Status and Enforcement

Selling the unapproved drug on social media or messaging apps is illegal in the UK, as it is an unlicensed medication that cannot be promoted or distributed for personal consumption under the Human Medicines Regulations 2012.

Some content creators try to circumvent the regulations by referring to the drug as a “research chemical” or citing it as “not for human consumption”. The substance is not a restricted drug, but promotion and supply can still violate medicines, advertising, and customer regulations, risking fines, legal action or prison.

Service Response and Content Elimination

Based on TikTok, the service has taken down violative material and banned related keywords and search suggestions. The organization stated it was dedicated to maintaining the platform secure and allocating resources in enhancing compliance measures.

Online Marketplace Activities

Investigations also discovered groups with up to 9,000 participants marketing retatrutide using Telegram's built-in search feature, which operates like a online catalog. Typing “retatrutide” immediately brings up channels with numerous of users, populated with images of slimming results, positive reviews and detailed instructions for preparing or injecting at residence.

Within minutes of joining one group, a vendor posted contact information, where most transactions take place. The vendor provided an guidebook and promised delivery within two days. When questioned whether the substance was authentic, one seller said: “You can’t be sure.” Another provided a photo of a alleged laboratory certificate. Not one inquired about weight, medical conditions or previous experience.

Item Information and Costs

Inside these communities, posts display black plastic parcels with Royal Mail labels, claiming to include fresh supplies. One message read: “It took eight of us to load them this morning.”

Customers can select between dry substance containers, mixed at home with sterile water, or ready-to-use injectors typically sold at 160 pounds for 20 milligrams. When questioned how much time a pen should be used, vendors give contradictory answers varying between a few weeks to “depends on your body”.

Platform Oversight and Safety Measures

A representative for the messaging service said it actively monitored harmful material on its platform including content that promoted the “misuse of controlled medications”. The organization noted that it removed “millions of pieces of harmful content each day”.

Medical Expert Cautions

“People are injecting substances they can’t verify. Even if the research behind retatrutide is sound, these online products may not contain what they claim,” stated a pharmacy expert, the director of pharmacy at Chemist4U.

Dr Crystal Wyllie of an online medical service connected the increase in interest to recent cost increases for authorized weight-loss medications such as Mounjaro. “With prices rising, individuals are using social media. But fake injections are extremely risky. You can’t be certain what’s inside or whether the conditions they were produced in was sterile,” she explained.

Her team has already encountered individuals injured by self-injection from unconfirmed sources. “We understand the frustration, but buying from Telegram or WhatsApp is taking chances with your well-being,” stated Wyllie. “These materials could be impure or improperly measured.”

Producer Statement

A representative from the pharmaceutical company stated the substance was in third stage research studies and had not been reviewed or authorized by any government authority anywhere in the world. “Therefore at this time no one can sell [it] for personal consumption,” they explained, noting that any item “falsely representing itself as a company investigational substance not yet authorized … may subject users to possibly serious medical dangers”.

Robert Reeves
Robert Reeves

Award-winning journalist specializing in data-driven investigations and international policy analysis.